The treatment of Chronic Candidiasis & Prostate Cancer Radiation with vitamins

Chronic Candidiasis and Prostate Cancer Radiation: Mitamins custom make quality formulas for the treatment of Chronic Candidiasis & Prostate Cancer Radiation with vitamins. A Chronic Candidiasis & Prostate Cancer Radiation formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Chronic Candidiasis and Prostate Cancer Radiation

  • Amount Per Serving
    % DV
    Vitamin A
    13000
    IU
    260%
    Vitamin C
    1100
    mg
    1833%
    Vitamin D
    600
    IU
    150%
    Vitamin E
    230
    IU
    767%
    Vitamin K
    90
    mcg
    113%
    Thiamin
    51.5
    mg
    3433%
    Riboflavin
    51.7
    mg
    3041%
    Niacin
    70
    mg
    350%
    Vitamin B6
    52
    mg
    2600%
    Folate
    1200
    mcg
    300%
    Vitamin B12
    56
    mcg
    933%
    Biotin
    350
    mcg
    117%
    Pantothenic Acid
    60
    mg
    600%
    Calcium
    600
    mg
    60%
    Iodine
    150
    mcg
    100%
    Magnesium
    290
    mg
    73%
    Zinc
    43.5
    mg
    290%
    Selenium
    270
    mcg
    386%
    Copper
    3
    mg
    150%
    Manganese
    1.8
    mg
    90%
    Chromium
    320
    mcg
    267%
    Molybdenum
    150
    mcg
    200%
    Potassium
    99
    mg
    3%
    Choline Bitartrate
    105
    mg
    *
    Inositol
    55
    mg
    *
    PABA
    51
    mg
    *
    Alpha Lipoic Acid
    100
    mg
    *
    Lactobacillus acidolphilus
    100
    mg
    *
    CoQ-10
    50
    mg
    *
  • Amount Per Serving
    % DV
    Flax Seed Powder
    100
    mg
    *
    Lecithin
    100
    mg
    *
    Lutein
    1100
    mcg
    *
    Lycopene
    30300
    mcg
    *
    MSM
    250
    mg
    *
    Boron
    500
    mcg
    *
    Nickel
    5
    mcg
    *
    Silicon
    2
    mg
    *
    Tin
    10
    mcg
    *
    Trace Mineral Blend
    3
    mg
    *
    Vanadium
    10
    mcg
    *
    Bioflavonoid Concentrate
    200
    mg
    *
    Garlic Extract
    100
    mg
    *
    Ginkgo Extract
    80
    mg
    *
    Eleuthero Extract
    100
    mg
    *
    Grape Seed Extract
    100
    mg
    *
    Green Tea Extract
    100
    mg
    *
    Maitake Extract
    100
    mg
    *
    Reishi Extract
    100
    mg
    *
    Shiitake Extract
    100
    mg
    *
    Milk Thistle Extract
    100
    mg
    *
    Quercetin
    100
    mg
    *
    L-Glutathione Reduced
    100
    mg
    *
    Amino Acid Mix
    50
    mg
    *
    Calcium D-Glucarate
    200
    mg
    *
    Ashwagandha Extract
    500
    mg
    *
    Dandelion Extract
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Chronic Candidiasis and Prostate Cancer Radiation
Serving Size:4-5

Chronic Candidiasis and Prostate Cancer Radiation Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
The first reported findings from an international, Phase 3 study showed that more than two-thirds of patients with moderate to severe plaque psoriasis receiving two doses of ustekinumab (CNTO 1275) achieved at least a 75 percent reduction in psoriasis at week 12, the primary endpoint of the study, as measured by the Psoriasis Area and Severity Index (PASI 75).
US FDA Grants Orphan Drug Status To Immtech's Pafuramidine For Treatment Of African Sleeping Sickness
Immtech Pharmaceuticals, Inc. (Amex: IMM) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to pafuramidine (DB289) for treating Human African Trypanosomiasis (HAT), also known as African sleeping sickness.
This information concerning the support of Chronic Candidiasis and Prostate Cancer Radiation treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments